secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0001214659-23-015278
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro regains Nasdaq minimum bid price compliance
----------------------------------------------------------

- Received Nasdaq notice on Nov 15, 2023 confirming compliance with $1.00 minimum bid price rule.
- Bid price closed at or above $1.00 for 10 consecutive trading days through Nov 13, 2023.
- Company had been at risk of delisting since January 2023; hearing extended deadline to Nov 15.
- Separate MVLS deficiency remains; Alzamend must regain compliance with $35M market value rule by March 25, 2024.
- Press release issued November 16, 2023 announcing the compliance notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923015278/0001214659-23-015278-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923015278/z11152318k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-23-015278

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer